These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
-
Jun 11, 2018
SAN DIEGO, June 11, 2018 -- Pfenex (NYSE American: PFNX) and Alvogen today announced entering into an agreement granting Alvogen exclusive rights to commercialize Pfenex’s lead drug candidate,...
-
May 30, 2018
SAN DIEGO, May 30, 2018 -- Pfenex Inc. (NYSE American: PFNX) announced today that it will be presenting at the Jefferies 2018 Global Healthcare Conference in New York City. President and Chief...
-
May 29, 2018
SAN DIEGO, May 25, 2018 — Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology® to improve...
-
May 23, 2018
SAN DIEGO, May 23, 2018 —Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology® to improve...
-
May 22, 2018
SAN DIEGO, May 22, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology®
May 14, 2018- PF708-301 findings show comparable overall profiles of PF708 and Forteo®Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to improve protein therapies for unmet...
-
May 10, 2018
Pfenex Inc. (NYSE American: PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfēnex Expression Technology® to improve protein therapies for unmet...
-
Apr 30, 2018
Pfenex Inc. (NYSE American: PFNX) announced today that its first quarter 2018 financial results will be released on Thursday, May 10, 2018, after the market close. Pfenex management will host a...
-
Apr 18, 2018
Pfenex Inc. (NYSE AMERICAN: PFNX) and China NT Pharma Group Company Limited (NT Pharma) (HKG:1011) today announced an agreement under which Pfenex granted NT Pharma non-exclusive development and...
-
Mar 15, 2018
Pfenex Inc. (NYSE American: PFNX) is a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology® to improve protein therapies for...